Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
16.73
-1.12 (-6.27%)
Sep 21, 2026, 2:00 PM EDT - Market open
Summit Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $18 | Hold | Maintains | $18 | +7.59% | Sep 21, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $41 | Buy | Maintains | $41 | +145.07% | Sep 14, 2026 |
| Citi | Citi | Buy Maintains $40 | Buy | Maintains | $40 | +139.09% | Sep 14, 2026 |
| UBS | UBS | Buy Maintains $33 | Buy | Maintains | $33 | +97.25% | Sep 14, 2026 |
| Jefferies | Jefferies | Buy Upgrades $15 → $25 | Buy | Upgrades | $15 → $25 | +49.43% | Sep 9, 2026 |
| Clear Street | Clear Street | Buy Reiterates $31 | Buy | Reiterates | $31 | +85.30% | Sep 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 3, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $30 | Buy | Maintains | $30 | +79.32% | Aug 27, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.